| Net Cash Provided by (Used in) Operating Activities |
$969,000 |
USD |
19% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$467,000 |
USD |
-79% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$232,000 |
USD |
0% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
85,000,000 |
shares |
|
Q1 2025 |
Q1 2025 |
| Common Stock, Shares, Issued |
4,324,091 |
shares |
|
Q1 2025 |
Q1 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
|
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$734,000 |
USD |
-193% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$21,670,000 |
USD |
10% |
Q4 2024 |
FY 2025 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.24 |
pure |
0% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Gross |
$21,670,000 |
USD |
10% |
Q4 2024 |
FY 2025 |
| Payments to Acquire Property, Plant, and Equipment |
$0 |
USD |
-100% |
Q1 2024 |
Q1 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$15,312,000 |
USD |
-2.8% |
Q4 2024 |
FY 2025 |
| Unrecognized Tax Benefits |
$331,000 |
USD |
0% |
Q1 2025 |
Q1 2025 |
| Additional Paid in Capital |
$138,515,000 |
USD |
2.5% |
Q1 2025 |
Q1 2025 |
| Depreciation, Depletion and Amortization |
$1,042,000 |
USD |
-7% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$0 |
USD |
-100% |
Q4 2024 |
FY 2025 |
| Share-based Payment Arrangement, Expense |
$1,895,000 |
USD |
-6.6% |
Q1 2025 |
Q1 2025 |
| Interest Expense |
$1,747,000 |
USD |
73% |
Q3 2024 |
Q3 2025 |